Pitmans schreef op 30 september 2020 13:58:
Wsl. ook de v erklaring dat de DE-overheid nog in curetis zat. €350k, dat is wel een paar miljoen extra beurswaarde waard.
**EDIT** Nu al weer terug naar $2.28 , de boodschap is doorgevallen.
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators Wed, September 30, 2020, 1:30 PM GMT+2
Project: AI based Assay Development for carbapenem-resistance based on porin loss and efflux pump overexpression in Gram-negative bacteria
Project is part of the Research Campus InfectoGnostics and includes project partners at the University Hospital Jena, Institute for Infectious Diseases and Infection Control
GAITHERSBURG, Md., and HOLZGERLINGEN, Germany, Sept. 30, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today the award of a German Federal Government grant to its subsidiary, Curetis GmbH, and collaborators at the Research Campus InfectoGnostics. The project is coordinated by Jena University Hospital and designed to use artificial intelligence (AI) based assay development for carbapenem-resistance based on porin loss and efflux pump overexpression in Gram-negative bacteria.
Specifically, the project expected to start in September 2020 and run until August 2025 with overall funding of more than 350 thousand Euros provided by Federal German Ministry of Education and Research.